Genzyme | search
Click here to view Genzyme news from 60+ newspapers.
Bookmark or Share- Sanofi Pharmaceuticals - Healthcare Innovations | Sanofi USADiscover how Sanofi, a global pharmaceutical company, is shaping healthcare in the US with innovative solutions and treatments.
- Genzyme Corporation Company Information - Drugs.comDrug class: lysosomal enzymes. For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). Genzyme Corporation manufactures, markets and/or distributes more than 10 drugs in the U.S.
- Eleven years after buying Genzyme, Sanofi officially ditches ... - STATEleven years after Sanofi bought Genzyme for about $20.1 billion, the parent company said Thursday it will no longer call its specialty care unit Sanofi Genzyme ― just Sanofi, as part of a ...
- How a 15-year-old Genzyme drug shortage became a legal ... - PharmaVoiceA manufacturing problem from 15 years ago and the resulting prolonged drug shortage is at the heart of newly revived litigation against Sanofi’s Genzyme. An appeals court overturned the dismissal of a 2020 lawsuit brought by patients who allege they were harmed by Genzyme’s handling of a shortage of its drug Fabrazyme.
- Genzyme - WikipediaGenzyme (also known as Genzyme Transgenics Corp or GTC Biotherapeutics) was an American biotechnology company based in Cambridge, Massachusetts. From its acquisition in 2011 to 2022 Genzyme operated as a fully owned subsidiary of Sanofi. In 2010, Genzyme was the world's third-largest biotechnology company, employing more than 11,000 people ...
More
